185 related articles for article (PubMed ID: 10681333)
1. Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species.
Zhong W; Jeffries MW; Georgopapadakou NH
Antimicrob Agents Chemother; 2000 Mar; 44(3):651-3. PubMed ID: 10681333
[TBL] [Abstract][Full Text] [Related]
2. IPC synthase as a useful target for antifungal drugs.
Sugimoto Y; Sakoh H; Yamada K
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):311-22. PubMed ID: 15578972
[TBL] [Abstract][Full Text] [Related]
3. An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity.
Kuroda M; Hashida-Okado T; Yasumoto R; Gomi K; Kato I; Takesako K
Mol Gen Genet; 1999 Mar; 261(2):290-6. PubMed ID: 10102364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of yeast inositol phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay.
Zhong W; Murphy DJ; Georgopapadakou NH
FEBS Lett; 1999 Dec; 463(3):241-4. PubMed ID: 10606729
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene.
Nagiec MM; Nagiec EE; Baltisberger JA; Wells GB; Lester RL; Dickson RC
J Biol Chem; 1997 Apr; 272(15):9809-17. PubMed ID: 9092515
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.
Aeed PA; Young CL; Nagiec MM; Elhammer AP
Antimicrob Agents Chemother; 2009 Feb; 53(2):496-504. PubMed ID: 19047657
[TBL] [Abstract][Full Text] [Related]
7. Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities.
Yano T; Aoyagi A; Kozuma S; Kawamura Y; Tanaka I; Suzuki Y; Takamatsu Y; Takatsu T; Inukai M
J Antibiot (Tokyo); 2007 Feb; 60(2):136-42. PubMed ID: 17420564
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.
Figueiredo JM; Dias WB; Mendonça-Previato L; Previato JO; Heise N
Biochem J; 2005 Apr; 387(Pt 2):519-29. PubMed ID: 15569002
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
14. Inositol phosphoryl transferases from human pathogenic fungi.
Heidler SA; Radding JA
Biochim Biophys Acta; 2000 Jan; 1500(1):147-52. PubMed ID: 10564728
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of inositol phosphorylceramide synthase and effects of aureobasidin A on growth and pathogenicity of Botrytis cinerea.
Wang XH; Guo XJ; Li HY; Gou P
J Gen Appl Microbiol; 2015; 61(4):108-16. PubMed ID: 26377130
[TBL] [Abstract][Full Text] [Related]
17. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
18. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
19. A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A.
Munusamy K; Vadivelu J; Tay ST
Rev Iberoam Micol; 2018; 35(2):68-72. PubMed ID: 29544734
[TBL] [Abstract][Full Text] [Related]
20. Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.
Manavathu EK; Dimmock JR; Vashishtha SC; Chandrasekar PH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2950-9. PubMed ID: 10582888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
